DK1294659T3 - Fremgangsmåde til isolering af katamin - Google Patents

Fremgangsmåde til isolering af katamin

Info

Publication number
DK1294659T3
DK1294659T3 DK01940028T DK01940028T DK1294659T3 DK 1294659 T3 DK1294659 T3 DK 1294659T3 DK 01940028 T DK01940028 T DK 01940028T DK 01940028 T DK01940028 T DK 01940028T DK 1294659 T3 DK1294659 T3 DK 1294659T3
Authority
DK
Denmark
Prior art keywords
catamine
isolating
isolating catamine
Prior art date
Application number
DK01940028T
Other languages
English (en)
Inventor
Russo Valter Freire Torres
De Souza Russo Elisa Mannochio
Original Assignee
Cristalia Produtos Quimicos E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristalia Produtos Quimicos E filed Critical Cristalia Produtos Quimicos E
Application granted granted Critical
Publication of DK1294659T3 publication Critical patent/DK1294659T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01940028T 2000-06-19 2001-06-18 Fremgangsmåde til isolering af katamin DK1294659T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0002693A BRPI0002693B8 (pt) 2000-06-19 2000-06-19 processo de obtenção dos enantiômeros da cetamina e seus sais farmaceuticamente aceitáveis
PCT/BR2001/000075 WO2001098265A2 (en) 2000-06-19 2001-06-18 Process for isolating enantiomers of racemic cetamine

Publications (1)

Publication Number Publication Date
DK1294659T3 true DK1294659T3 (da) 2008-03-17

Family

ID=37515961

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01940028T DK1294659T3 (da) 2000-06-19 2001-06-18 Fremgangsmåde til isolering af katamin

Country Status (11)

Country Link
US (1) US6743949B2 (da)
EP (1) EP1294659B1 (da)
AR (1) AR030938A1 (da)
AT (1) ATE378307T1 (da)
AU (1) AU7374401A (da)
BR (1) BRPI0002693B8 (da)
DE (1) DE60131397T2 (da)
DK (1) DK1294659T3 (da)
ES (1) ES2296757T3 (da)
PT (1) PT1294659E (da)
WO (1) WO2001098265A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060063802A1 (en) 2004-03-29 2006-03-23 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US9072662B2 (en) 2004-03-29 2015-07-07 Auris Medical Ag Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8268866B2 (en) 2004-03-29 2012-09-18 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
NZ566062A (en) 2005-09-28 2009-08-28 Auris Medical Ag Pharmaceutical compositions for the treatment of inner ear disorders comprising an arylcycloalkylamine such as ketamine and a biocompatible polymer
US8808263B2 (en) * 2010-01-14 2014-08-19 The Procter & Gamble Company Article of commerce including two-piece wearable absorbent article
BRPI1003620A2 (pt) 2010-09-03 2012-06-05 Ouro Fino Participacoes E Empreendimentos S A associação anestésica, composição anestésica, e, medicamento anestésico de uso veterinário
ES2862673T3 (es) 2011-12-12 2021-10-07 Zilentin AG Tratamiento del tinnitus mediante la modulación del cotransportador de cloruro NKCC1 en el sistema auditivo
RS62516B1 (sr) 2013-09-13 2021-11-30 Univ Chiba Nat Univ Corp Primena r-ketamina i njegove soli kao farmaceutskih proizvoda
US20160332962A1 (en) * 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
EP3753557A4 (en) 2018-02-15 2021-12-01 National University Corporation Chiba University PREVENTIVE OR THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES OR BONE DISEASES
CN110218157B (zh) * 2018-03-01 2022-08-23 江苏恒瑞医药股份有限公司 一种r-氯胺酮及其可药用盐的制备方法
MX2020011653A (es) 2018-05-04 2021-02-09 Perception Neuroscience Inc Métodos de tratamiento para el abuso de sustancias.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH535201A (de) * 1969-12-19 1973-03-31 Bristol Myers Co Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren
CA2202911A1 (en) * 1994-10-17 1996-04-25 Cor Peter Mathilde Gerard A'campo Process for separating enantiomers from a racemic mixture
DE19619665C2 (de) * 1996-05-15 2001-03-08 Goedecke Ag Racemattrennung von Ketamin

Also Published As

Publication number Publication date
EP1294659B1 (en) 2007-11-14
US20030212143A1 (en) 2003-11-13
EP1294659A2 (en) 2003-03-26
EP1294659A4 (en) 2005-06-22
WO2001098265B1 (en) 2002-10-24
WO2001098265A3 (en) 2002-08-15
ATE378307T1 (de) 2007-11-15
US6743949B2 (en) 2004-06-01
DE60131397D1 (de) 2007-12-27
BR0002693A (pt) 2004-07-06
BR0002693B1 (pt) 2013-12-24
BRPI0002693B8 (pt) 2021-05-25
WO2001098265A2 (en) 2001-12-27
ES2296757T3 (es) 2008-05-01
PT1294659E (pt) 2008-02-19
AR030938A1 (es) 2003-09-03
DE60131397T2 (de) 2008-09-18
AU7374401A (en) 2002-01-02

Similar Documents

Publication Publication Date Title
DK1132569T3 (da) Fremgangsmåde til behandling af en underjordisk formation
DK1257954T3 (da) Fremgangsmåde til fordeling af forsendelser
DK1249151T3 (da) Fremgangsmåde til cellegenvalgssignalering
DK1978747T3 (da) Fremgangsmåde til fjernelse af kodningsforvrængning
DK1016836T3 (da) Fremgangsmåde til tilvejebringelse af köling
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1259251T3 (da) Hidtil ukendt fremgangsmåde til nedregulering af amyloid
DK1480524T3 (da) Fremgangsmåde til isolering af lactoferrin
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DK1187231T3 (da) Metode til fremstilling af oxid-superleder
DK1350765T3 (da) Fremgangsmåde til fremstilling af jernoxider
DK1414492T3 (da) Fremgangsmåde til behandling af multipel myeloma
DK1261448T3 (da) Fremgangsmåde til samling af rörsamlinger
DK1539200T3 (da) Fremgangsmåde til behandling af multipel sklerose
DK1294659T3 (da) Fremgangsmåde til isolering af katamin
DK1345944T3 (da) Fremgangsmåde til isolering og oprensning af epothiloner
DK1314824T3 (da) Fremgangsmåde til konsolidering af jord
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK0987356T3 (da) Fremgangsmåde til trækning
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1578442T3 (da) Fremgangsmåde til isolering af endotoxiner
DK1286940T3 (da) Fremgangsmåde til fluormethylering af alkoholer
FI20000325A0 (fi) Menetelmä rakenteen rasituksen määrittämiseksi
DK1254159T3 (da) Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider
DK1311679T3 (da) Fremgangsmåde til inhibering af IL-22-induceret PAP1